Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution

Genes to Cells

Volumn 16, Issue 2, 2011, Pages 123-140

  Taguchi, Keiko ^a   Motohashi, Hozumi ^a   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2; UBIQUITIN PROTEIN LIGASE E3;

BINDING SITE; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CHEMOPROPHYLAXIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; MISSENSE MUTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DISCOVERY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTATION, MISSENSE; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; XENOBIOTICS;

EID: 78751703950     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2010.01473.x     Document Type: Review

References (108)

1. Adams, J., Kelso, R. & Cooley, L. (2000) The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol. 10, 17-24.
2. Aikawa, Y., Morimoto, K., Yamamoto, T., Chaki, H., Hashiramoto, A., Narita, H., Hirono, S. & Shiozawa, S. (2008) Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat. Biotechnol. 26, 817-823.
3. Bloom, D.A. & Jaiswal, A.K. (2003) Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278, 44675-44682.
4. Chan, J.Y., Han, X.L. & Kan, Y.W. (1993) Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl Acad. Sci. USA 90, 11371-11375.
5. Chan, K. & Kan, Y.W. (1999) Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl Acad. Sci. USA 96, 12731-12736.
6. Chen, W.M., Sun, Z., Wang, X.J., Jiang, T., Huang, Z.P., Fang, D.Y. & Zhang, D.D. (2009) Direct Interaction between Nrf2 and p21(Cip1/WAF1) Upregulates the Nrf2-Mediated Antioxidant Response. Mol. Cell 34, 663-673.
7. Copple, I.M., Lister, A., Obeng, A.D., Kitteringham, N.R., Jenkins, R.E., Layfield, R., Foster, B.J., Goldring, C.E. & Park, B.K. (2010) Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway. J. Biol. Chem. 285, 16782-16788.
8. Cullinan, S.B., Gordan, J.D., Jin, J., Harper, J.W. & Diehl, J.A. (2004) The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24, 8477-8486.
9. Dinkova-Kostova, A.T., Holtzclaw, W.D., Cole, R.N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M. & Talalay, P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl Acad. Sci. USA 99, 11908-11913.
10. Eggler, A.L., Liu, G., Pezzuto, J.M., van Breemen, R.B. & Mesecar, A.D. (2005) Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl Acad. Sci. USA 102, 10070-10075.
11. Eggler, A.L., Small, E., Hannink, M. & Mesecar, A.D. (2009) Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. Biochem. J. 422, 171-180.
12. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T. & Yamamoto, M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169-177.
13. Fahey, J.W., Zalcmann, A.T. & Talalay, P. (2001) The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 56, 5-51.
14. Fishbein, J.C. & Holland, R. (2010) Chemistry of the cysteine sensors in Keap1. Antioxid. Redox Signal. 13, 1749-1761.
15. Fujii, S., Sawa, T., Ihara, H., Tong, K.I., Ida, T., Okamoto, T., Ahtesham, A.K., Ishima, Y., Motohashi, H., Yamamoto, M. & Akaike, T. (2010) The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response. J. Biol. Chem. 285, 23970-23984.
16. Furukawa, M. & Xiong, Y. (2005) BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 25, 162-171.
17. Gartel, A.L. & Tyner, A.L. (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1, 639-649.
18. Higgins, L.G., Kelleher, M.O., Eggleston, I.M., Itoh, K., Yamamoto, M. & Hayes, J.D. (2009) Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol. Appl. Pharmacol. 237, 267-280.
19. Holland, R., Hawkins, A.E., Eggler, A.L., Mesecar, A.D., Fabris, D. & Fishbein, J.C. (2008) Prospective type 1 and type 2 disulfides of Keap1 protein. Chem. Res. Toxicol. 21, 2051-2060.
20. Homma, S., Ishii, Y., Morishima, Y., Yamadori, T., Matsuno, Y., Haraguchi, N., Kikuchi, N., Satoh, H., Sakamoto, T., Hizawa, N., Itoh, K. & Yamamoto, M. (2009) Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 15, 3423-3432.
21. Hong, F., Freeman, M.L. & Liebler, D.C. (2005a) Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 18, 1917-1926.
22. Hong, F., Sekhar, K.R., Freeman, M.L. & Liebler, D.C. (2005b) Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280, 31768-31775.
23. Huang, H.C., Nguyen, T. & Pickett, C.B. (2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769-42774.
24. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. & Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
25. Itoh, K., Tong, K.I. & Yamamoto, M. (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 36, 1208-1213.
26. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T. & Yamamoto, M. (2003) Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8, 379-391.
27. Jain, A., Lamark, T., Sjottem, E., Larsen, K.B., Awuh, J.A., Overvatn, A., McMahon, M., Hayes, J.D. & Johansen, T. (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576-22591.
28. Jain, A.K. & Jaiswal, A.K. (2006) Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 281, 12132-12142.
29. Jiang, T., Chen, N., Zhao, F., Wang, X.J., Kong, B., Zheng, W. & Zhang, D.D. (2010) High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 70, 5486-5496.
30. Kang, K.W., Lee, S.J., Park, J.W. & Kim, S.G. (2002) Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol. 62, 1001-1010.
31. Katoh, Y., Iida, K., Kang, M.I., Kobayashi, A., Mizukami, M., Tong, K.I., McMahon, M., Hayes, J.D., Itoh, K. & Yamamoto, M. (2005) Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch. Biochem. Biophys. 433, 342-350.
32. Kensler, T.W., Chen, J.G., Egner, P.A., et al. (2005) Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidem. Biomar. 14, 2605-2613.
33. Kim, Y.R., Oh, J.E., Kim, M.S., Kang, M.R., Park, S.W., Han, J.Y., Eom, H.S., Yoo, N.J. & Lee, S.H. (2010) Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J. Pathol. 220, 446-451.
34. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. & Yamamoto, M. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139.
35. Kobayashi, A., Kang, M.I., Watai, Y., Tong, K.I., Shibata, T., Uchida, K. & Yamamoto, M. (2006) Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26, 221-229.
36. Kobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y. & Yamamoto, M. (2009) The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29, 493-502.
37. Komatsu, M. & Ichimura, Y. (2010) Physiological significance of selective degradation of p62 by autophagy. FEBS Lett. 584, 1374-1378.
38. Komatsu, M., Kurokawa, H., Waguri, S., et al. (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223.
39. Komatsu, M., Waguri, S., Koike, M., et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149-1163.
40. Lau, A., Wang, X.J., Zhao, F., Villeneuve, N.F., Wu, T., Jiang, T., Sun, Z., White, E. & Zhang, D.D. (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 30, 3275-3285.
41. Levonen, A.L., Landar, A., Ramachandran, A., Ceaser, E.K., Dickinson, D.A., Zanoni, G., Morrow, J.D. & Darley-Usmar, V.M. (2004) Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378, 373-382.
42. Li, J., Johnson, D., Calkins, M., Wright, L., Svendsen, C. & Johnson, J. (2005) Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 83, 313-328.
43. Li, L., Kobayashi, M., Kaneko, H., Nakajima-Takagi, Y., Nakayama, Y. & Yamamoto, M. (2008) Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish. J. Biol. Chem. 283, 3248-3255.
44. Liby, K., Royce, D.B., Williams, C.R., Risingsong, R., Yore, M.M., Honda, T., Gribble, G.W., Dmitrovsky, E., Sporn, T.A. & Sporn, M.B. (2007) The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res. 67, 2414-2419.
45. Lu, M., Nakamura, R.M., Dent, E.D., Zhang, J.Y., Nielsen, F.C., Christiansen, J., Chan, E.K. & Tan, E.M. (2001) Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am. J. Pathol. 159, 945-953.
46. Magnani, M., Crinelli, R., Bianchi, M. & Antonelli, A. (2000) The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr. Drug Targets 1, 387-399.
47. Matsumoto, N., Ezaki, J., Komatsu, M., Takahashi, K., Mineki, R., Taka, H., Kikkawa, M., Fujimura, T., Takeda-Ezaki, M., Ueno, T., Tanaka, K. & Kominami, E. (2008) Comprehensive proteomics analysis of autophagy-deficient mouse liver. Biochem. Biophys. Res. Commun. 368, 643-649.
48. Maynard, M.A. & Ohh, M. (2004) von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am. J. Nephrol. 24, 1-13.
49. McMahon, M., Itoh, K., Yamamoto, M. & Hayes, J.D. (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278, 21592-21600.
50. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. & Hayes, J.D. (2004) Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 279, 31556-31567.
51. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. & Hayes, J.D. (2006) Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 281, 24756-24768.
52. Melnick, A., Ahmad, K.F., Arai, S., Polinger, A., Ball, H., Borden, K.L., Carlile, G.W., Prive, G.G. & Licht, J.D. (2000) In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20, 6550-6567.
53. Moi, P., Chan, K., Asunis, I., Cao, A. & Kan, Y.W. (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl Acad. Sci. USA 91, 9926-9930.
54. Motohashi, H., O'Connor, T., Katsuoka, F., Engel, J.D. & Yamamoto, M. (2002) Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294, 1-12.
55. Motohashi, H. & Yamamoto, M. (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557.
56. Muller, T., Langner, C., Fuchsbichler, A., et al. (2004) Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 39, 963-969.
57. Nioi, P. & Nguyen, T. (2007) A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 362, 816-821.
58. Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S. & Yoshida, T. (2003) Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 285, C334-C342.
59. Ogura, T., Tong, K.I., Mio, K., Maruyama, Y., Kurokawa, H., Sato, C. & Yamamoto, M. (2010) Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc. Natl Acad. Sci. USA 107, 2842-2847.
60. Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., Shibata, T., Yamamoto, M. & Hirohashi, S. (2008) Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68, 1303-1309.
61. Ohtake, F., Baba, A., Takada, I., Okada, M., Iwasaki, K., Miki, H., Takahashi, S., Kouzmenko, A., Nohara, K., Chiba, T., Fujii-Kuriyama, Y. & Kato, S. (2007) Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446, 562-566.
62. Okawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T.W. & Yamamoto, M. (2006) Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339, 79-88.
63. O'Reilly, M.A. (2005) Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid. Redox Signal. 7, 108-118.
64. Padmanabhan, B., Tong, K.I., Kobayashi, A., Yamamoto, M. & Yokoyama, S. (2008) Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1. J. Synchrotron Radiat. 15, 273-276.
65. Padmanabhan, B., Tong, K.I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.I., Kobayashi, A., Yokoyama, S. & Yamamoto, M. (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689-700.
66. Pi, J., Bai, Y., Reece, J.M., Williams, J., Liu, D., Freeman, M.L., Fahl, W.E., Shugar, D., Liu, J., Qu, W., Collins, S. & Waalkes, M.P. (2007) Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 42, 1797-1806.
67. Pintard, L., Willis, J.H., Willems, A., Johnson, J.L., Srayko, M., Kurz, T., Glaser, S., Mains, P.E., Tyers, M., Bowerman, B. & Peter, M. (2003) The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 425, 311-316.
68. Prestera, T., Zhang, Y., Spencer, S.R., Wilczak, C.A. & Talalay, P. (1993) The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enzyme Regul. 33, 281-296.
69. Rachakonda, G., Xiong, Y., Sekhar, K.R., Stamer, S.L., Liebler, D.C. & Freeman, M.L. (2008) Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem. Res. Toxicol. 21, 705-710.
70. Ramos-Gomez, M., Kwak, M.K., Dolan, P.M., Itoh, K., Yamamoto, M., Talalay, P. & Kensler, T.W. (2001) Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl Acad. Sci. USA 98, 3410-3415.
71. Satoh, H., Moriguchi, T., Taguchi, K., Takai, J., Maher, J.M., Suzuki, T., Winnard, P.T. Jr, Raman, V., Ebina, M., Nukiwa, T. & Yamamoto, M. (2010) Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 31, 1833-1843.
72. Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., Izumi, M., Shirasawa, T. & Lipton, S.A. (2008) Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 104, 1116-1131.
73. Sawa, T., Zaki, M.H., Okamoto, T., Akuta, T., Tokutomi, Y., Kim-Mitsuyama, S., Ihara, H., Kobayashi, A., Yamamoto, M., Fujii, S., Arimoto, H. & Akaike, T. (2007) Protein S-guanylation by the biological signal 8-nitroguanosine 3 ', 5 '-cyclic monophosphate. Nat. Chem. Biol. 3, 727-735.
74. Seglen, P.O., Gordon, P.B. & Holen, I. (1990) Non-selective autophagy. Semin. Cell Biol. 1, 441-448.
75. Sekhar, K.R., Rachakonda, G. & Freeman, M.L. (2010) Cysteine-based regulation of the CUL3 adaptor protein Keap1. Toxicol. Appl. Pharmacol. 244, 21-26.
76. Sekhar, K.R., Yan, X.X. & Freeman, M.L. (2002) Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene 21, 6829-6834.
77. Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M. & Hirohashi, S. (2008a) Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135, 1358-1368.
78. Shibata, T., Ohta, T., Tong, K.I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M. & Hirohashi, S. (2008b) Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA 105, 13568-13573.
79. Singh, A., Boldin-Adamsky, S., Thimmulappa, R.K., Rath, S.K., Ashush, H., Coulter, J., Blackford, A., Goodman, S.N., Bunz, F., Watson, W.H., Gabrielson, E., Feinstein, E. & Biswal, S. (2008) RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res. 68, 7975-7984.
80. Singh, A., Misra, V., Thimmulappa, R.K., Lee, H., Ames, S., Hoque, M.O., Herman, J.G., Baylin, S.B., Sidransky, D., Gabrielson, E., Brock, M.V. & Biswal, S. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PloS Med. 3, 1865-1876.
81. Strnad, P., Zatloukal, K., Stumptner, C., Kulaksiz, H. & Denk, H. (2008) Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies. Biochim. Biophys. Acta 1782, 764-774.
82. Sun, Z., Huang, Z. & Zhang, D.D. (2009) Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS ONE 4, e6588.
83. Surh, Y.J., Kundu, J.K. & Na, H.K. (2008) Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 74, 1526-1539.
84. Sussan, T.E., Rangasamy, T., Blake, D.J., et al. (2009) Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc. Natl Acad. Sci. USA 106, 250-255.
85. Taguchi, K., Maher, J.M., Suzuki, T., Kawatani, Y., Motohashi, H. & Yamamoto, M. (2010) Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol. Cell. Biol. 30, 3016-3026.
86. Takahashi, T., Sonobe, M., Menju, T., Nakayama, E., Mino, N., Iwakiri, S., Nagai, S., Sato, K., Miyahara, R., Okubo, K., Hirata, T., Date, H. & Wada, H. (2010) Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer. J. Surg. Oncol. 101, 500-506.
87. Tong, K.I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T. & Yamamoto, M. (2006a) Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol. 26, 2887-2900.
88. Tong, K.I., Kobayashi, A., Katsuoka, F. & Yamamoto, M. (2006b) Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387, 1311-1320.
89. Tong, K.I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S. & Yamamoto, M. (2007) Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 27, 7511-7521.
90. Van Beveren, C., van Straaten, F., Curran, T., Muller, R. & Verma, I.M. (1983) Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 32, 1241-1255.
91. Wakabayashi, N., Dinkova-Kostova, A.T., Holtzclaw, W.D., Kang, M.I., Kobayashi, A., Yamamoto, M., Kensler, T.W. & Talalay, P. (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl Acad. Sci. USA 101, 2040-2045.
92. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D.R., Harada, T., Engel, J.D. & Yamamoto, M. (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35, 238-245.
93. Wang, J.S., Shen, X., He, X., Zhu, Y.R., Zhang, B.C., Wang, J.B., Qian, G.S., Kuang, S.Y., Zarba, A., Egner, P.A., Jacobson, L.P., Munoz, A., Helzlsouer, K.J., Groopman, J.D. & Kensler, T.W. (1999) Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl Cancer Inst. 91, 347-354.
94. Wang, R., An, J., Ji, F., Jiao, H., Sun, H. & Zhou, D. (2008) Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem. Biophys. Res. Commun. 373, 151-154.
95. Wang, X.J., Hayes, J.D. & Wolf, C.R. (2006) Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. Cancer Res. 66, 10983-10994.
96. Watt, R.A., Shatzman, A.R. & Rosenberg, M. (1985) Expression and characterization of the human c-myc DNA-binding protein. Mol. Cell. Biol. 5, 448-456.
97. Xu, L., Wei, Y., Reboul, J., Vaglio, P., Shin, T.H., Vidal, M., Elledge, S.J. & Harper, J.W. (2003) BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 425, 316-321.
98. Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H. & Yamamoto, M. (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol. 28, 2758-2770.
99. Yates, M.S., Kwak, M.K., Egner, P.A., Groopman, J.D., Bodreddigari, S., Sutter, T.R., Baumgartner, K.J., Roebuck, B.D., Liby, K.T., Yore, M.M., Honda, T., Gribble, G.W., Sporn, M.B. & Kensler, T.W. (2006) Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-, 12-dioxooleana-1, 9(11)-dien-28-oyl]imidazole. Cancer Res. 66, 2488-2494.
100. Yates, M.S., Tran, Q.T., Dolan, P.M., Osburn, W.O., Shin, S., McCulloch, C.C., Silkworth, J.B., Taguchi, K., Yamamoto, M., Williams, C.R., Liby, K.T., Sporn, M.B., Sutter, T.R. & Kensler, T.W. (2009) Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30, 1024-1031.
101. Yoh, K., Itoh, K., Enomoto, A., Hirayama, A., Yamaguchi, N., Kobayashi, M., Morito, N., Koyama, A., Yamamoto, M. & Takahashi, S. (2001) Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 60, 1343-1353.
102. Zatloukal, K., French, S.W., Stumptner, C., Strnad, P., Harada, M., Toivola, D.M., Cadrin, M. & Omary, M.B. (2007) From Mallory to Mallory-Denk bodies: what, how and why? Exp. Cell Res. 313, 2033-2049.
103. Zhang, D.D. & Hannink, M. (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23, 8137-8151.
104. Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J. & Hannink, M. (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24, 10941-10953.
105. Zhang, J.Y., Chan, E.K.L., Peng, X.X. & Tan, E.M. (1999) A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J. Exp. Med. 189, 1101-1110.
106. Zhang, P., Singh, A., Yegnasubramanian, S., Esopi, D., Kombairaju, P., Bodas, M., Wu, H., Bova, S.G. & Biswal, S. (2010) Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol. Cancer Ther. 9, 336-346.
107. Zhang, Y., Talalay, P., Cho, C.G. & Posner, G.H. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl Acad. Sci. USA 89, 2399-2403.
108. Zhuang, M., Calabrese, M.F., Liu, J., Waddell, M.B., Nourse, A., Hammel, M., Miller, D.J., Walden, H., Duda, D.M., Seyedin, S.N., Hoggard, T., Harper, J.W., White, K.P. & Schulman, B.A. (2009) Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol. Cell 36, 39-50.